A comparison of two different treatments for major depression with psychotic features: ziprasidone vs. combined sertraline and haloperidol

Trial Profile

A comparison of two different treatments for major depression with psychotic features: ziprasidone vs. combined sertraline and haloperidol

Completed
Phase of Trial: Phase II/III

Latest Information Update: 23 Sep 2014

At a glance

  • Drugs Ziprasidone (Primary) ; Haloperidol; Sertraline
  • Indications Psychotic affective disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Aug 2009 Actual patient number (72) added as reported by ClinicalTrials.gov.
    • 11 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top